Mettl3-mediated mRNA m<sup>6</sup>A methylation promotes dendritic cell activation.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 31015515.
- Also identified by DOI 10.1038/s41467-019-09903-6 and PMC identifier 6478715.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
N6-methyladenosine (m<sup>6</sup>A) modification plays important roles in various cellular responses by regulating mRNA biology. However, how m<sup>6</sup>A modification is involved in innate immunity via affecting the translation of immune transcripts remains to be further investigated. Here we report that RNA methyltransferase Mettl3-mediated mRNA m<sup>6</sup>A methylation promotes dendritic cell (DC) activation and function. Specific depletion of Mettl3 in DC resulted in impaired phenotypic and functional maturation of DC, with decreased expression of co-stimulatory molecules CD40, CD80 and cytokine IL-12, and reduced ability to stimulate T cell responses both in vitro and in vivo. Mechanistically, Mettl3-mediated m<sup>6</sup>A of CD40, CD80 and TLR4 signaling adaptor Tirap transcripts enhanced their translation in DC for stimulating T cell activation, and strengthening TLR4/NF-κB signaling-induced cytokine production. Our findings identify a new role for Mettl3-mediated m<sup>6</sup>A modification in increasing translation of certain immune transcripts for physiological promotion of DC activation and DC-based T cell response.
Medical subject headings
- Adenosine
- Dendritic Cells
- Epigenesis, Genetic
- Methyltransferases
- RNA, Messenger
- T-Lymphocytes